Home › Funds › DRIEHAUS CAPITAL MANAGEMENT LLC › PTCT

DRIEHAUS CAPITAL MANAGEMENT LLC position in PTCT

PTC THERAPEUTICS INC · Health Care

DRIEHAUS CAPITAL MANAGEMENT LLC reported holding 1,236,579 shares of PTCT (PTC THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$80.1M, representing 0.56% of its reported portfolio and ranking #47 among its reported holdings. DRIEHAUS CAPITAL MANAGEMENT LLC has disclosed PTCT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)1.24M sh
Reported value held$80.11M
Portfolio Weight0.56%
First reportedQ4 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How DRIEHAUS CAPITAL MANAGEMENT LLC's PTCT position evolved

DRIEHAUS CAPITAL MANAGEMENT LLC first disclosed a stake in PTCT in Q4 2024 at 1,041,059 shares (US$47.0M). The position peaked in Q2 2026 at 1,440,107 shares, worth US$117.5M. Across 8 filings, DRIEHAUS CAPITAL MANAGEMENT LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,236,579 shares valued at US$80.1M — a reduction of -203,528 shares quarter over quarter.. Notable position changes include a 45% increase in Q1 2025 (shares fell 4% over the following quarter), a 30% trim in Q2 2025 (shares rose 26% over the following quarter), a 42% increase in Q2 2026 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 1.04M $46.99M New
Q1 2025 1.51M $77.08M Add
Q2 2025 1.06M $51.72M Reduce
Q3 2025 1.13M $69.46M Add
Q4 2025 1.14M $86.30M Hold
Q1 2026 1.02M $69.20M Reduce
Q2 2026 1.44M $117.47M Add
Q3 2026 1.24M $80.11M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PTCT and 13F data

PTCT (PTC THERAPEUTICS INC) is a Health Care company. 42 other funds we track also report a position in PTCT — the largest reported positions include TORONTO DOMINION BANK (US$176.7M), WESTFIELD CAPITAL MANAGEMENT CO LP (US$174.9M), TANG CAPITAL MANAGEMENT LLC (US$122.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PTCT

All PTCT fund holders →

FAQ

How long has DRIEHAUS CAPITAL MANAGEMENT LLC held PTCT?

DRIEHAUS CAPITAL MANAGEMENT LLC has disclosed PTCT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is DRIEHAUS CAPITAL MANAGEMENT LLC's current position in PTCT?

As of Q3 2026, DRIEHAUS CAPITAL MANAGEMENT LLC holds 1.24M shares of PTCT (PTC THERAPEUTICS INC), valued at $80.11M, representing 0.56% of its reported portfolio and ranking #47.

Has DRIEHAUS CAPITAL MANAGEMENT LLC been buying or selling PTCT?

In the latest 13F filing (Q3 2026), DRIEHAUS CAPITAL MANAGEMENT LLC reduced its position in PTCT. The position peaked in Q2 2026 at 1.44M shares.

Which other funds hold PTCT?

Other major institutional holders of PTCT include TORONTO DOMINION BANK, WESTFIELD CAPITAL MANAGEMENT CO LP, TANG CAPITAL MANAGEMENT LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.